期刊文献+

2种盐酸特比萘芬乳膏体外透皮扩散试验研究 被引量:6

Study of Transdermal Diffusion Experiment of 2 Kinds of Terbinafine Hydrochloride Cream in Vitro
原文传递
导出
摘要 目的:考察2种盐酸特比萘芬乳膏体外透过皮肤量及其在皮肤中贮药量以阐明其起效途径。方法:采用改良Franz扩散池,离体小型猪皮肤,取2种盐酸特比萘芬乳膏(国产与进口制剂)各1.0g进行体外透皮扩散试验,以反相高效液相色谱法测定接受液中盐酸特比萘芬的含量(计算透过率)和皮肤中贮药量。结果:国产及进口制剂中盐酸特比萘芬的体外皮肤透过率均低于0.05%,皮肤贮药量分别为(43.1±7.5)、(42.2±4.9)μg·cm-(2n=6)。结论:2种制剂中盐酸特比萘芬几乎不透过皮肤,皮肤贮药量相近,表明二者药效和安全性基本一致,并主要发挥局部治疗作用。 OBJECTIVE: To investigate the transdermal amount and dermal loading quantity of 2 kinds of Terbinafine hydrochloride (TH) cream to interpret the acting approach. METHODS: 2 kinds of TH cream (domestic and imported preparations) 1.0 g were used for in vitro transdermal diffusion test of miniature pigs skin using modified Franz diffusion cell. TH concentration in re- ceiving solution and dermal loading quantity of TH were determined by RP-HPLC. RESULTS: The transdermal amounts of TH in domestic and imported preparations were below 0.05% and the dermal loading quantities were (43.1 ± 7.5) μg. cm-2 and (42.2 ± 4.9) μg.cm-2 (n=6), respectively. CONCLUSION: 2 kinds of TH cream hardly pass through derma, and dermal loading quantites of TH are similar between them. It indicates that efficacy and safety of the 2 kinds of cream are in substantial agreement and they mainly play region effect.
出处 《中国药房》 CAS CSCD 北大核心 2011年第29期2723-2725,共3页 China Pharmacy
基金 广州市重大科技专项计划(2008A1-E4101-4)
关键词 盐酸特比萘芬乳膏 体外透皮扩散试验 皮肤贮药量 Terbinafine hydrochloride cream Transdermal diffusion experiment Dermal loading quantity
  • 相关文献

参考文献6

二级参考文献14

共引文献27

同被引文献49

  • 1熊非,朱家壁,田煦,汪豪.RP-HPLC法测定灯盏花素纳米脂质体药物含量及包封率[J].药物分析杂志,2004,24(4):364-366. 被引量:8
  • 2王欣雪,陈元成.1%盐酸特比萘芬乳膏治疗浅部真菌病的疗效[J].中国中西医结合皮肤性病学杂志,2006,5(3):164-164. 被引量:5
  • 3张代平,杨义雄.脂质体制剂的研究概况[J].海峡药学,2006,18(6):21-24. 被引量:7
  • 4JENSENJ C. Pharmacokinetics of lamisil in human [ J]. J Dermato Treat, 1990,14(2) : 1-18. 被引量:1
  • 5ZHOU Yan,WEI Yuhui, LIU Huanxiang, et ah Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopeeuroides loaded by a transmembrane pH-gradient method[ J]. AAPS Pharm Sci Tech,2010,11 (3) : 1350-1358. 被引量:1
  • 6WOKOVICH A M, PRODDUTURI S, DOUB W H, et al. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute [ J ]. Eur J Pharm Biopharm,2006,64(1) :1-8. 被引量:1
  • 7KAWESKI SS. Topical anesthetic creams[J]. Plast Reconstr Surg,2008,121(6) :2161 - 2165. 被引量:1
  • 8WEI HL, CHEN Y,XU LF, et al. Percutaneous penetration kinet- ics of lidocaine and prilocaine in two local anesthetic formulations assessed by in vivo microdialysis in pigs [ J]. Bid Pharm Bull, 2007,30(4) :830 - 834. 被引量:1
  • 9ONI G,BROWN S,KENKEL J. Comparison of five commonly-a- vailable, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexyli- dide (MEGX) [J]. Aesthet Surg J,2012,32(4) :495 -503. 被引量:1
  • 10LI XJ,WANG J, LI GQ, et al. Evaluation of calcipotriol transder- mal permeation through pig,rat and mouse skin using liquid chro- matography-tandem mass spectrometry [ J]. Biomed Chromatogr,2013,27(12):1714 -1719. 被引量:1

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部